- Home
- PAM vs MMSI Comparison
PAM vs MMSI Comparison
Compare PAM & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PAM | MMSI |
|---|---|---|
| Founded | 1945 | 1987 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.0B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | PAM | MMSI |
|---|---|---|
| Price | $87.05 | $68.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $94.50 | ★ $100.38 |
| AVG Volume (30 Days) | 244.8K | ★ 668.9K |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 4.93 |
| EPS | N/A | ★ 2.13 |
| Revenue | N/A | ★ $1,515,906,000.00 |
| Revenue This Year | $204,770.38 | $8.78 |
| Revenue Next Year | $16.65 | $5.76 |
| P/E Ratio | ★ $13.79 | $32.05 |
| Revenue Growth | N/A | ★ 11.75 |
| 52 Week Low | $54.95 | $66.34 |
| 52 Week High | $94.50 | $99.26 |
Technical Indicators
Market Signals| Indicator | PAM | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 55.61 | 40.48 |
| Support Level | $86.41 | $66.76 |
| Resistance Level | $89.90 | $71.57 |
| Average True Range (ATR) | 2.96 | 1.80 |
| MACD | 0.06 | 0.47 |
| Stochastic Oscillator | 59.20 | 38.08 |
Price Performance
Historical ComparisonAbout PAM Pampa Energia S.A.
Pampa Energia SA and its subsidiaries are engaged in the Energy business, mainly in oil and gas production and power generation. The firm's operating business segments are Oil and Gas, Generation, Petrochemicals, Holding, Transportation, and Others. The company derives the maximum revenue from the oil and gas segment.
About MMSI Merit Medical Systems Inc.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.